References
- Zhang W, Ji Z, Wang L, et al. A meta-analysis of HBsAg-positive rate among general Chinese populations aged 1–59 years. Infect Dis (Lond). 2015;47:878–888.
- MacLachlan JH, Locarnini S, Cowie BC. Estimating the global prevalence of hepatitis B. Lancet. 2015;386:1515–1517.
- Zampino R, Boemio A, Sagnelli C, et al. Hepatitis B virus burden in developing countries. World J Gastroenterol. 2015;21:11941–11953.
- Perera J. Chapter 8, Hepatitis B vaccine. SLMA guidelines and information on vaccines. Colombo, Sri Lanka: Sri Lanka Medical Association; 2017.
- Petruzziello A, Marigliano S, Loquercio G, et al. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22:7824–7840.
- Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–1342.
- Silva HJD, Vitarana T, Ratnatunga N, et al. Prevalence of hepatitis C virus markers in Sri Lankan patients with alcoholic cirrhosis. J Gastroenterol Hepatol. 1994;9:381–384.
- Niriella MA, Hapangama A, Luke HP, et al. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates. Ceylon Med J. 2015;60:18–20.
- Senevirathna D, Amuduwage S, Weerasingam S, et al. Hepatitis C virus in healthy blood donors in Sri Lanka. Asian J Transfus Sci. 2011;5:23–25.
- Fernando S, Fernando SS, Sheriff M, et al. Antibodies to hepatitis C virus in patients who have had multiple transfusions in Sri Lanka. Ceylon Med J. 2001;46:91–94.